← 返回前沿论文

NK 细胞可靶向去势抵抗性前列腺癌干细胞并涉及脱颗粒通路

英文原题:NK Cells Can Target Castration-resistant Prostate Cancer Stem Cells With the Involvement of Degranulation Pathway.

PubMed 2025/08/01(内容时间) Anticancer Res Q4 · IF 1.8(JCR 2025)

研究概要

这些观察结果提示,利用NK细胞靶向CRPC干细胞可能有助于建立抑制CRPC发展的新型治疗策略。

研究思路结论见上方概要

去势抵抗性前列腺癌(CRPC)具有致死性且对治疗耐药。为降低CRPC风险,需要直接消除肿瘤干细胞的策略,但针对肿瘤干细胞的有前景的方法尚未建立。自然杀伤(NK)细胞已知对肿瘤干细胞表现出强效的细胞毒性活性。在本研究中,我们旨在阐明具有干性特征的CRPC细胞是否比不具有干性特征的CRPC细胞对NK细胞更敏感。

从CRPC细胞系PC-3(PC3)中通过三维肿瘤球培养方法分离出PC-3干样(PC3-stem)细胞。随后将每种类型的肿瘤细胞(PC3或PC3-stem)与人NK样细胞系KHYG-1共培养,并使用WST-8法和结晶紫染色测定细胞活力。使用实时PCR测定mRNA水平,并使用流式细胞术和ELISA评估每种蛋白的表达。

KHYG-1细胞对PC3-stem细胞的细胞毒性比PC3细胞更强。此外,NK细胞对PC3-stem细胞更具细胞毒性的机制与NKG2D-MICA/B介导的脱颗粒途径有关。

展开英文摘要原文

BACKGROUND/AIM: Castration-resistant prostate cancer (CRPC) is lethal and refractory to therapy. To reduce the risk of CRPC, a direct elimination strategy of cancer stem cells is needed, but a promising approach to target cancer stem cells has not yet been established. Natural killer (NK) cells are known to exhibit potent cytotoxic activity against cancer stem cells. In this study, we aimed to clarify whether CRPC cells with stemness characteristics are more sensitive to NK cells than CRPC cells without stemness features. MATERIALS AND METHODS: PC-3 stem-like (PC3-stem) cells separated from the CRPC cell line PC-3 (PC3) using a three-dimensional tumor sphere culture method. Each type of tumor cells (PC3 or PC3-stem) were then co-cultured with the human NK-like cell line KHYG-1, and cell viability was determined using the WST-8 method and crystal violet staining. mRNA levels were determined using real-time PCR, and the expression of each protein was evaluated using flow cytometry and ELISA. RESULTS: KHYG-1 cells exhibited more potent cytotoxicity against PC3-stem cells than PC3 cells. In addition, the mechanism that leads to the NK cell cytotoxicity favoring toward PC3-stem cells was associated with the NKG2D-MICA/B-mediated degranulation pathway. CONCLUSION: These observations raise the possibility that targeting CRPC stem cells with NK cells may lead to the establishment of novel therapeutic strategies for the suppression of CRPC development.

论文信息

作者
Hattori A、Seki T、Kato K、Virgona N、Miyakoshi Y、Kohno K、Yano T
第一作者单位
Laboratory of Molecular Bromatology, Graduate School of Sports Health, Toyo University, Tokyo, Japan.Italy
通讯作者单位
Research Institute of Life Innovation, Toyo University, Tokyo, Japan yano_t@toyo.jp.Japan
期刊
Anticancer research2025 Aug
原文标识
PubMed 40750437 · DOI 10.21873/anticanres.17682